2025
Statistical methods for cost-effectiveness analysis of left-truncated and right-censored survival data with treatment delays
Khudyakov P, Xu L, Yang C, Spiegelman D, Wang M. Statistical methods for cost-effectiveness analysis of left-truncated and right-censored survival data with treatment delays. Journal Of The Royal Statistical Society Series C (Applied Statistics) 2025, qlaf035. DOI: 10.1093/jrsssc/qlaf035.Peer-Reviewed Original ResearchIncremental net benefitExcellent finite sample propertiesRight-censored survival dataCost-effectiveness analysisFinite sample propertiesIncremental cost-effectiveness ratioExtensive simulation studyLeft-truncatedSample propertiesSimulation studyNet benefitsSurvival dataCost-effectiveness ratioHealth settingsSwitching treatmentDelay scenariosEstimationPublic health settingsTreatment initiationDelayInferenceStatistical methods
2017
Evaluating Public Health Interventions: 7. Let the Subject Matter Choose the Effect Measure: Ratio, Difference, or Something Else Entirely.
Spiegelman D, Khudyakov P, Wang M, Vanderweele TJ. Evaluating Public Health Interventions: 7. Let the Subject Matter Choose the Effect Measure: Ratio, Difference, or Something Else Entirely. American Journal Of Public Health 2017, 108: 73-76. PMID: 29161073, PMCID: PMC5719681, DOI: 10.2105/ajph.2017.304105.Peer-Reviewed Original ResearchConceptsRisk factor distributionRisk ratioLife yearsEffect measuresDisability-adjusted life yearsIncremental cost-effectiveness ratioPopulation attributable riskQuality-adjusted life yearsCost-effectiveness ratioPublic health interventionsPublic health evaluationYears of lifeMeasure of effectRisk factorsRelative riskStudy populationRisk differenceHealth interventionsIntervention effectsAbsolute effect measuresHealth evaluationExternal generalizabilityRiskAbsolute measuresPopulation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply